Optimizing the number of variants tracked to follow disease burden with circulating tumor DNA assays in metastatic colorectal cancer.

Boutin, Mélina; Topham, James T; Feilotter, Harriet; Kennecke, Hagen F; Couture, Félix; Harb, Mohammed; Kavan, Peter; Berry, Scott; Lim, Howard J; Goffin, John R; Ahmad, Chaudhary; Lott, Anthony; Renouf, Daniel J; Jonker, Derek J; Tu, Dongsheng; O'Callaghan, Chris J; Chen, Eric X; Loree, Jonathan M.

Afiliação

Boutin M; Division of Medical Oncology, BC Cancer, Vancouver, BC, Canada Centre Intégré de Cancérologie de la Montérégie, Université de Sherbrooke, QC, Canada.
Topham JT; Pancreas Center BC, Vancouver, BC, Canada.
Feilotter H; Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada.
Kennecke HF; Providence Cancer Institute, Portland, OR, USA.
Couture F; CHU de Québec-Université Laval, QC, Canada.
Harb M; Moncton Hospital, Moncton, NB, Canada.
Kavan P; Segal Cancer Centre, Montreal, QC, Canada.
Berry S; Department of Oncology, Queen's University, Kingston, ON, Canada.
Lim HJ; Division of Medical Oncology, BC Cancer, Vancouver, BC, Canada.
Goffin JR; Juravinski Cancer Centre, Hamilton, ON, Canada.
Ahmad C; Dr. H. Bliss Murphy Cancer Centre, St. John's, NL, Canada.
Lott A; Sunnybrook Health Sciences, Toronto, ON, Canada.
Renouf DJ; Division of Medical Oncology, BC Cancer, Vancouver, BC, Canada Pancreas Center BC, Vancouver, BC, Canada.
Jonker DJ; The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada.
Tu D; Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada.
O'Callaghan CJ; Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada.
Chen EX; Princess Margaret Cancer Centre, Toronto, ON, Canada.
Loree JM; Division of Medical Oncology, BC Cancer, 600 West 10th Avenue, Vancouver, BC V5Z 4E6, Canada.